The prime-boost concept applied to HIV preventive vaccines

Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.

Biologicals : journal of the International Association of Biological Standardization·2010

Use of predictive markers of HIV disease progression in vaccine trials.

Vaccine·2009

Development of a cytomegalovirus vaccine: lessons from recent clinical trials.

Expert opinion on biological therapy·2001

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.

The Journal of infectious diseases·2001

A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.

The Journal of infectious diseases·2001

A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates.

Journal of virology·2000

Longitudinal trends in copy-years viremia associated with mpox acquisition but not mpox severity in people with HIV.

AIDS (London, England)·2026

Sex differences in long-acting cabotegravir trough concentrations in the SEARCH study in Kenya and Uganda.

AIDS (London, England)·2026

Changes in neurodevelopmental outcomes from 24 to 36 months among children HIV-exposed uninfected (CHEU) and HIV-unexposed (CHU).

AIDS (London, England)·2026

Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.

AIDS (London, England)·2026

Ninety-six-week observational outcomes of long-acting injectable HIV therapy in people with adherence challenges, including people who use drugs.

AIDS (London, England)·2026

Evolving drivers of preexposure prophylaxis discontinuation among US MSM, 2018-2024.

AIDS (London, England)·2026

The economic impact of opportunistic PSA screening: a real-world cost analysis from China amid evolving policy landscape.

Expert review of pharmacoeconomics & outcomes research·2026

Emergency obstetric and newborn care: A priority measure to achieve rapid decline in maternal and newborn mortality in sub-Saharan Africa.

African journal of reproductive health·2026

HPV vaccine awareness, uptake, intention, and influencing factors among medical students in Anhui, China: A cross-sectional study.

Human vaccines & immunotherapeutics·2026

From the grassroots up: Redefining Public Health Surveillance in Nigeria through Community Action Networks.

Nigerian medical journal : journal of the Nigeria Medical Association·2026

Evaluating the Effectiveness of a Proposed 11-Step Community-Based Interventional Program That Educates, Assesses Risk, and Overcomes Barriers to Complete Screening Colonoscopy Among African Americans.

Cureus·2026

Antimicrobial stewardship in practice: determinants of prescription behaviour and developing interventions to improve surgical prophylaxis in a Rwandan tertiary hospital-a mixed methods study using the behaviour change wheel.

Antimicrobial resistance and infection control·2026

Related Experiment Videos

The prime-boost concept applied to HIV preventive vaccines

Related Concept Videos

Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.

Use of predictive markers of HIV disease progression in vaccine trials.

Development of a cytomegalovirus vaccine: lessons from recent clinical trials.

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.

A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.

A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates.

Longitudinal trends in copy-years viremia associated with mpox acquisition but not mpox severity in people with HIV.

Sex differences in long-acting cabotegravir trough concentrations in the SEARCH study in Kenya and Uganda.

Changes in neurodevelopmental outcomes from 24 to 36 months among children HIV-exposed uninfected (CHEU) and HIV-unexposed (CHU).

Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.

Ninety-six-week observational outcomes of long-acting injectable HIV therapy in people with adherence challenges, including people who use drugs.

Evolving drivers of preexposure prophylaxis discontinuation among US MSM, 2018-2024.

The economic impact of opportunistic PSA screening: a real-world cost analysis from China amid evolving policy landscape.

Emergency obstetric and newborn care: A priority measure to achieve rapid decline in maternal and newborn mortality in sub-Saharan Africa.

HPV vaccine awareness, uptake, intention, and influencing factors among medical students in Anhui, China: A cross-sectional study.

From the grassroots up: Redefining Public Health Surveillance in Nigeria through Community Action Networks.

Evaluating the Effectiveness of a Proposed 11-Step Community-Based Interventional Program That Educates, Assesses Risk, and Overcomes Barriers to Complete Screening Colonoscopy Among African Americans.

Antimicrobial stewardship in practice: determinants of prescription behaviour and developing interventions to improve surgical prophylaxis in a Rwandan tertiary hospital-a mixed methods study using the behaviour change wheel.

Related Experiment Videos

The prime-boost concept applied to HIV preventive vaccines

Related Concept Videos

Related Articles